SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030797
Filing Date
2019-08-08
Accepted
2019-08-08 16:16:29
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20190630.htm 10-Q 2116142
2 EX-31.1 cala-ex311_7.htm EX-31.1 15733
3 EX-32.1 cala-ex321_6.htm EX-32.1 7511
  Complete submission text file 0001564590-19-030797.txt   6101122

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cala-20190630.xml EX-101.INS 1247266
5 XBRL TAXONOMY EXTENSION SCHEMA cala-20190630.xsd EX-101.SCH 41316
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20190630_cal.xml EX-101.CAL 41755
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20190630_def.xml EX-101.DEF 95053
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20190630_lab.xml EX-101.LAB 322870
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20190630_pre.xml EX-101.PRE 234357
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 191009743
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences